Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes?

Ann Intern Med. 2008 Dec 2;149(11):841; author reply 841-2. doi: 10.7326/0003-4819-149-11-200812020-00023.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Coronary Disease / prevention & control*
  • Diabetes Mellitus, Type 2 / complications*
  • Humans
  • Hypolipidemic Agents / therapeutic use*

Substances

  • Hypolipidemic Agents